How have SHL shares performed in 2024?

Siemens Healthineers' stock was trading at €52.60 at the beginning of 2024. Since then, SHL shares have decreased by 1.0% and is now trading at €52.08. View the best growth stocks for 2024 here .

Is Siemens Healthineers a good dividend stock?

Siemens Healthineers (ETR:SHL) pays an annual dividend of €0.95 per share and currently has a dividend yield of 1.68%. The dividend payout ratio is 70.37%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Siemens Healthineers own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM) , Illumina (ILMN) , Regeneron Pharmaceuticals (REGN) , Broadcom (AVGO) , Gilead Sciences (GILD) , Moderna (MRNA) , Vertex Pharmaceuticals (VRTX) , Adobe (ADBE) and Applied Materials (AMAT) .

ETR:SHL

Siemens Healthineers (SHL) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)

Free SHL Stock Alerts

€52.08

-0.58 (-1.10%)

(As of 04/17/2024 ET)

Compare

Today's Range: €52.02
▼
€52.68
50-Day Range: €52.52
▼
€57.70
52-Week Range: €44.39
▼
€58.14

Volume: 443,070 shs
Average Volume: N/A
Market Capitalization: $58.33 billion

P/E Ratio: 38.58
Dividend Yield: 1.82%
Price Target: N/A

Stock Analysis Chart Headlines

Get Siemens Healthineers alerts:

Ad DTI

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

About Siemens Healthineers Stock (ETR:SHL)

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

SHL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SHL Stock News Headlines

April 14, 2024 | finance.yahoo.com

Interested In Siemens Healthineers' (ETR:SHL) Upcoming €0.95 Dividend? You Have Four Days Left

April 11, 2024 | finance.yahoo.com

Investing in Siemens Healthineers (ETR:SHL) five years ago would have delivered you a 57% gain

April 18, 2024 | Darwin (Ad)

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

February 1, 2024 | fxstreet.com

BoE expected to follow Fed with unchanged rates

December 11, 2023 | seekingalpha.com

Siemens Healthineers: Strong Return, Still A 'Buy'

November 26, 2023 | lse.co.uk

Siemens Healthineers Share Price (1SHL.MI)

November 3, 2023 | money.usnews.com

Siemens Healthineers Reviews Options for Diagnostics Unit - Source

November 2, 2023 | finance.yahoo.com

Siemens Healthineers (ETR:SHL) shareholders have earned a 9.0% CAGR over the last three years

April 18, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

July 25, 2023 | finance.yahoo.com

A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare

June 29, 2023 | finance.yahoo.com

Are Investors Undervaluing Siemens Healthineers AG (ETR:SHL) By 21%?

June 13, 2023 | reuters.com

Siemens Healthineers: A breakthrough in cancer treatment

June 8, 2023 | msn.com

REDBURN LIMITED Maintains Siemens Healthineers (FWB:SHL) Buy Recommendation

June 8, 2023 | msn.com

BERENBERG Maintains Siemens Healthineers (FWB:SHL) Buy Recommendation

May 12, 2023 | msn.com

DTG and SHL: Analysts say BUY These Two DAX 40 Shares

May 12, 2023 | marketwatch.com

Cloud-Computing In Healthcare Market Prospects, Size, Share, Demand and Current Trends Analysis Till 2027

April 26, 2023 | msn.com

The first MRI dedicated to radiotherapy simulation in Romania and in the region, MAGNETOM Sola RT from Siemens Healthineers portfolio, is now available at Amethyst radiotherapy ...

April 19, 2023 | msn.com

Siemens Healthineers inaugurates MRI facility at Bengaluru

April 12, 2023 | benzinga.com

Siemens and Microsoft drive industrial productivity with generative artificial intelligence

April 4, 2023 | finance.yahoo.com

RS Abdi Waluyo acquires the world's first photon-counting CT to improve clinical outcomes for patients in Indonesia

February 9, 2023 | finance.yahoo.com

Siemens Healthineers AG's (ETR:SHL) CEO Compensation Is Looking A Bit Stretched At The Moment

December 18, 2022 | marketwatch.com

Medical Telemonitoring System Market : Analysis, Forecast, Size, New Trends and Insights, Update, COVID-19 Impact

November 27, 2022 | yahoo.com

Siemens Healthineers' (ETR:SHL) Dividend Will Be Increased To €0.95

November 21, 2022 | finance.yahoo.com

Siemens Healthineers AG's (ETR:SHL) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

November 9, 2022 | msn.com

Siemens Healthineers 4Q Net Pft EUR636M

October 31, 2022 | finance.yahoo.com

Siemens Healthineers and University of Miami Health System Enter Value Partnership Agreement to Transform Healthcare

May 24, 2022 | finance.yahoo.com

PrecisionOS Partners with Siemens Healthineers for VR-based Surgical Training Development

See More Headlines

Receive SHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ETR
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: ETR:SHL
CUSIP: N/A
CIK: N/A
Web: www.healthcare.siemens.de
Phone: 49 69 6682 6602
Fax: N/A
Employees: 71,400
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): €1.35
Trailing P/E Ratio: 38.58
Forward P/E Ratio: 18.78
P/E Growth: 2.7
Net Income: $1.52 billion
Net Margins: 6.97%
Pretax Margin: N/A
Return on Equity: 8.40%
Return on Assets: 3.00%

Debt

Debt-to-Equity Ratio: 89.44
Current Ratio: 1.12
Quick Ratio: 0.71

Sales & Book Value

Annual Sales: $21.78 billion
Price / Sales: 2.68
Cash Flow: €1.34 per share
Price / Cash Flow: 38.96
Book Value: €16.14 per share
Price / Book: 3.23

Miscellaneous

Outstanding Shares: 1,120,000,000
Free Float: N/A
Market Cap: $58.33 billion
Optionable: Not Optionable
Beta: 0.73

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Bernhard Montag (Age 55)
President, CEO & Chairman of Management Board
Comp: $3.15M
Dr. Jochen Schmitz Ph.D. (Age 58)
CFO & Member of Management Board
Comp: $1.86M
Ms. Darleen Caron (Age 60)
Chief Human Resources Officer, Labor Director & Member of Management Board
Comp: $1.66M
Ms. Elisabeth Staudinger-Leibrecht (Age 54)
Member of Management Board
Comp: $1.15M
Mr. Marc Koebernick
Head of Investor Relations
Christian Klaussner
Executive Vice President of Finance
Andre Hartung
Head of Imaging
Carsten Bertram
Head of Advanced Therapies
Ms. Sharon J. Bracken (Age 53)
Head of Diagnostics
Jerry Wang
Head of China

Key Competitors

View All Competitors

Should I Buy Siemens Healthineers Stock? SHL Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Siemens Healthineers AG:

Siemens Healthineers appoints Vivek Kanade as new Head for its Middle East and Africa operations, indicating a focus on expanding and strengthening presence in key markets.
Strong presence in the medical devices industry, offering a diverse range of diagnostic and therapeutic products and services to healthcare providers worldwide.
Continuous innovation in imaging and diagnostic technologies, such as the latest MRI, CT, and ultrasound systems, ensuring competitiveness in the market.
Varian segment providing advanced cancer care technologies and solutions, catering to the increasing demand for oncology treatments.
Comprehensive customer service offerings, including maintenance, repair, training, and digital healthcare consulting, enhancing customer satisfaction and loyalty.

Cons

Investors should be bearish about investing in Siemens Healthineers AG for these reasons:

Market competition in the medical devices industry is intense, leading to pricing pressures and potential impact on profit margins.
Dependency on healthcare spending trends and regulatory environment, which can affect demand for products and services unpredictably.
Volatile stock price movements due to external factors like global economic conditions and geopolitical events, requiring a cautious investment approach.
Potential challenges in integrating acquisitions or new technologies, which could lead to operational disruptions and financial risks.
Exposure to currency exchange rate fluctuations, impacting financial performance and investor returns.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Siemens Healthineers pros and cons to contact@marketbeat.com.

SHL Stock Analysis - Frequently Asked Questions

How have SHL shares performed in 2024?: Siemens Healthineers' stock was trading at €52.60 at the beginning of 2024. Since then, SHL shares have decreased by 1.0% and is now trading at €52.08.
View the best growth stocks for 2024 here.
Is Siemens Healthineers a good dividend stock?: Siemens Healthineers (ETR:SHL) pays an annual dividend of €0.95 per share and currently has a dividend yield of 1.68%. The dividend payout ratio is 70.37%. This payout ratio is at a healthy, sustainable level, below 75%.
What other stocks do shareholders of Siemens Healthineers own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Broadcom (AVGO), Gilead Sciences (GILD), Moderna (MRNA), Vertex Pharmaceuticals (VRTX), Adobe (ADBE) and Applied Materials (AMAT).

This page (ETR:SHL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial